Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Update on Continuation Proposals

14 Jan 2016 07:00

RNS Number : 8126L
BlueCrest AllBlue Fund Ltd
14 January 2016
 



 

BlueCrest AllBlue Fund Limited (the "Company")

14 January 2016

Update on Continuation Proposals

Further to the Company's announcement on 9 December 2015, the Board is pleased to announce that, having completed its review of manager proposals received by the Company and consulted with its major shareholders, it proposes to recommend the replacement of its existing management arrangements with a mandate given to J.P. Morgan Asset Management ("JPMAM") group(1). The proposed appointment is subject to, amongst other things, detailed due diligence which is being performed on behalf of the Company and finalisation of engagement terms. In addition, the proposed appointment will be subject to shareholder approval as part of the re-organisation proposals (the "Proposals") to be put forward in due course.

As part of the Proposals, it is intended that the Company will invest substantially all of its assets (net of the cash exit opportunity described below) in the Highbridge Multi-Strategy Fund ("HMSF"). HMSF is a global multi-strategy hedge fund, managed by Highbridge Capital Management ("HCM"), focused on relative value strategies with idiosyncratic sources of return that invests in 12 distinct strategies across Fundamental Equity, Quantitative Equity, Event Driven Equity, Capital Structure Arbitrage, Convertible & Volatility Arbitrage, Fundamental Credit and Macro. Since its inception (1 January 1993) HMSF has achieved 10.76% annualised net returns, 6.89% annualised volatility and low beta relative to equity and credit indices.(2)

The JPMAM group is the largest manager of closed-end investment companies in the UK with 23 investment companies under its management and £9.2bn of assets under management(3). HCM was founded in 1992 as one of the industry's first multi-strategy hedge fund managers. Today, it is a global alternative investment manager with $29 billion in AUM(4). HCM maintains a staff of over 380 employees, including ~150 investment professionals and has offices in London, New York and Hong Kong.(4) HCM established a strategic partnership with JPMAM in 2004. All investment, capital allocation and risk management decisions for HMSF are independent of JPMAM.

It is currently intended to put forward the Proposals by the end of January/early February. As previously announced, the Proposals will provide shareholders with an opportunity to receive a full cash exit at NAV less costs (the "Cash Exit"), representing the net realisation proceeds from the AllBlue Limited redemptions, as soon as practicable following receipt by the Company. Proceeds of AllBlue Limited assets not capable of immediate realisation will subsequently be invested into HMSF with the exception of those proceeds due to shareholders pursuant to the Cash Exit.

Following implementation of the Proposals, it is intended to introduce a quarterly redemption facility, for up to 20% of the prevailing net asset value of the Company at NAV less costs, which may be implemented at the Board's discretion in each quarterly period. It is intended that net redemption proceeds would be paid to shareholders as soon as practicable following receipt by the Company.

A further announcement in relation to the Proposals will be made in due course.

For further information contact:

JTC (Guernsey) Limited, Secretary

Tel: +44 (0) 1481 702 400

Jefferies International Limited

Gary Gould/ Alex Collins

Tel: + 44 (0) 20 7029 8000

Dexion Capital Plc

Robin Bowie/ Katie Standley

Tel: +44 (0) 20 7832 0900

 

 

PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS

There can be no assurance that the Company's or HMSF's return objectives will be realized or that the Company or HMSF will not experience losses.

 

(1) The brand name for the Asset Management business of J.P. Morgan Chase & Co.

(2) As of 30 November 2015 net of all applicable fees and expenses. Returns are estimated and unaudited for 2015.

(3) As of 31 December 2015.

(4) As of 1 December 2015.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRUOUKRNWAAAAR
Date   Source Headline
29th Jul 20204:32 pmRNSNet Asset Value - Weekly Estimate
29th Jul 20202:17 pmRNS2019 Redemption Portfolio
29th Jul 20202:15 pmRNSNet Asset Value - Month End Final
21st Jul 20204:22 pmRNSNet Asset Value - Weekly Estimate
16th Jul 20202:44 pmRNSNet Asset Value - Weekly Estimate
8th Jul 20201:13 pmRNSNet Asset Value - Weekly Estimate
2nd Jul 20205:11 pmRNSProvision 4 of the UK Corporate Governance Code
2nd Jul 202010:03 amRNSNet Asset Value(s) - Weekly Estimate
26th Jun 20203:11 pmRNSHolding(s) in Company
24th Jun 20205:07 pmRNSNet Asset Value - Weekly Estimate
23rd Jun 20205:16 pmRNS2019 Redemption Portfolio
23rd Jun 20205:15 pmRNSNet Asset Value(s) - Month End Final
17th Jun 202012:46 pmRNSNet Asset Value(s) - Weekly Estimate
12th Jun 202011:27 amRNSNet Asset Value(s) - Weekly Estimate
4th Jun 20202:39 pmRNSNet Asset Value(s) - Weekly Estimate
28th May 20204:17 pmRNSNet Asset Value(s) - Month End Final
28th May 20204:08 pmRNS2019 Redemption Portfolio
28th May 20203:46 pmRNSNet Asset Value(s) - Weekly Estimate
21st May 20205:01 pmRNSNet Asset Value(s) - Weekly Estimate
15th May 20203:42 pmRNSNet Asset Value(s) - Weekly Estimate
6th May 20204:06 pmRNSNet Asset Value(s) - Weekly Estimate
5th May 20201:58 pmRNSDisclosure of rights attached to equity shares
5th May 20201:47 pmRNSDirector/PDMR Shareholding
4th May 20205:16 pmRNS2019 Redemption Portfolio
4th May 20204:41 pmRNSNet Asset Value(s) - Month End Final
1st May 202010:11 amRNSCorrection to Disclosure of Notifiable Interests
30th Apr 20203:39 pmRNSNet Asset Value(s) - Weekly Estimate
28th Apr 20206:31 pmRNSDirector/PDMR Shareholding
27th Apr 20207:00 amRNSNotice of AGM
27th Apr 20207:00 amRNSAnnual Financial Report
23rd Apr 20204:53 pmRNSNet Asset Value(s) - Weekly Estimate
17th Apr 20203:39 pmRNSNet Asset Value(s) - Weekly Estimate
17th Apr 20209:15 amRNSNet Asset Value(s) - Weekly Estimate
14th Apr 20205:12 pmRNSCash Exit Payment
9th Apr 20205:39 pmRNSNet Asset Value(s) - Monthly Estimate
2nd Apr 20202:53 pmRNS2019 Redemption Portfolio
2nd Apr 20202:41 pmRNSNet Asset Value(s) - Weekly Estimate
26th Mar 20205:05 pmRNSNet Asset Value(s) - Month End Final
26th Mar 20204:53 pmRNSNet Asset Value(s) - Weekly Estimate
19th Mar 20201:31 pmRNSNet Asset Value(s)- Weekly Estimate
13th Mar 202011:41 amRNSHolding(s) in Company
12th Mar 20209:46 amRNSNet Asset Value(s) - Weekly Estimate
9th Mar 202012:20 pmRNSNet Asset Value(s) - Weekly Estimate
3rd Mar 20205:02 pmRNS2019 Redemption Portfolio
2nd Mar 20205:29 pmRNSNet Asset Value(s) - Month End Final
26th Feb 20203:33 pmRNSNet Asset Value(s) - Weekly Estimate
20th Feb 20202:05 pmRNSResult of EGM
19th Feb 20203:50 pmRNSNet Asset Value(s) - Weekly Estimate
12th Feb 20205:13 pmRNSNet Asset Value(s) - Weekly Estimate
7th Feb 20209:17 amRNS2019 Redemption Portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.